Brachytherapy Market by Dose Type (Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy, Pulse Dose Rate Brachytherapy, and Image-Guided Brachytherapy), Device (Applicators, Seeds, and After Loaders), Application (Breast Cancer, Prostate Cancer, Gynecological Cancer, Cervical Cancer, Skin Cancer, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2023 – 2031
The global brachytherapy market size was USD 950.7 Mn in 2022 and is likely to reach USD 1720.5 Mn by 2031, expanding at a CAGR of 7.5% during 2023–2031. The market growth is attributed to the rising cancer cases, growing preference for speedy cancer treatments, technological advancements, and supportive regulations by the various governments.
In brachytherapy treatment, a closed radiation source is placed in a small implant container, which is then planted in the cancer patient’s body. The implants used in this therapy are recognized per their size and materials, such as capsules, balloons, pellets, seeds, wires, ribbons, needles, and so on. The implants, no matter what size they are, are placed as close to the cancerous tumor as possible, to gain maximum results without harming the healthy cells.
Brachytherapy is performed in a closed hospital environment of an operating room to keep control of radiation. The patient is given anesthesia to make them either fall into a deep sleep or numb the area which is to be operated on during implant.
The applicators such as metal or plastic tubes are used for placing implants into the body tissue or cavity. Medical imaging solutions including X-rays, ultrasound, magnetic resonance imaging (MRI), and CT scan are used during the implant procedure to zero in on the place where the implants are to be placed in the body.
Brachytherapy enables delivering a higher amount of radiation to the cancer-affected area than conventional external radiation therapies. The highly concentrated radiation allows the maximum killing of cancer cells, without affecting the surrounding normal tissues.
The market report finds that the COVID-19 pandemic affected the brachytherapy market. As most of the healthcare establishments around the world focused on treating COVID-19 patients, the therapies were postponed as cancer patients desired to stay away from infection risks. The market growth further slowed down due to lesser budget allocations for buying equipment for cancer therapy by hospitals and specialty clinics over the last few years. The market is expected to resurge from COVID-19-caused decline as hospital and specialty clinics have started operating normally post vaccinations.
Brachytherapy Market Dynamics
The research report presents a complete market overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global brachytherapy market report has up-to-date insights about market scenarios that can shape the overall market performance and output during the forecast period, 2023 to 2031.
Major Drivers
Cancer cases are rising across the world each year, owing to factors such as poor lifestyles, smoking habits, drug addiction, alcoholism, and stressful living, among others. As brachytherapy is effective against major cancer types, its demand is anticipated to boost in the coming years.
As per the statistics given by the World Health Organization (WHO) cancer was one of the major reasons of death in 2020 worldwide. According to WHO reports, the most commonly diagnosed cancer type in 2020 were breast cancer (2.26 million), lung cancer (2.21 million), colon & rectum cancer (1.93 million), prostate cancer (1.41 million), skin cancer (1.20 million), and stomach cancer (1.09 million). This increasing prevalence of cancer is driving brachytherapy, as the demand for safe and efficient cancer therapy is growing among cancer treatment-taking patients.
Existing Restraints
The limited access to skilled professionals and lack of advanced medical devices across most of the healthcare establishments around the world, especially in developing regions is anticipated to hamper the brachytherapy market growth. Brachytherapy requires to be performed by a skillful professional and also needs advanced medical devices such as bio-imaging, monitoring, and others.
The involvement of radiation therapy means that healthcare facilities need to have the proper technology, machines, and operating rooms to deliver effective and safe treatments. However, in most parts of the worldwide healthcare systems such facilities, skills, and advanced medical devices are available in a limited means. These factors are expected to restrain the global market growth during the forecast period.
Emerging Opportunities
Healthcare budgets and spending are rising in emerging economies around the world, which is anticipated to provide substantial growth opportunities for the global market players. The disposable income and lifestyle in countries such as India, Japan, China, and others are consistently evolving owing to increased urbanization, technology use, and industrialization.
Cancer patients in developing regions are likely to prefer less invasive cancer treatment therapies that give speedy results and require fewer complications. In addition, the healthcare budgets allocated by governments and private institutions on advanced therapies are increasing, which is anticipated to create lucrative expansion opportunities for the prominent players in the brachytherapy market.
Scope of Brachytherapy Market Report
The report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Brachytherapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Dose Type (Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy, Pulse Dose Rate Brachytherapy, and Image-Guided Brachytherapy), Device (Applicators, Seeds, and After Loaders), and Application (Breast Cancer, Prostate Cancer, Gynecological Cancer, Cervical Cancer, Skin Cancer, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Elekta; Isoray Inc.; BEBIG Medical GmbH; Theragenics; CIVCO Medical Solutions; BD; Sun Nuclear Corporation; iCAD Inc.; Panacea Medical Technologies Pvt. Ltd.; Merit Medical Systems.; Varian Medical Systems, Inc.; ARGON MEDICAL; Best Vascular, Inc.; Boston Scientific Corporation; Best Theratronics Ltd; CNMC Company Inc.; MEDraysintell; Best Medical International, Inc.; SIR-Spheres; Hologic, Inc.; Xoft, Inc.; AngioDynamics; and IsoAid. |
Market Segment Insights
Based on dose type, the global brachytherapy market is divided into low-dose rate (LDR) brachytherapy, high-dose rate (HDR) brachytherapy, pulse dose rate (PDR) brachytherapy, and image-guided brachytherapy. The high-dose rate (HDR) brachytherapy segment is expected to generate higher revenues during the forecast period. The growth of the segment is attributed to the high efficiency and speedy procedure benefits provided by high-dose rate brachytherapy. HDR therapy held the largest share of market revenues in 2021 and is expected to be at the forefront of radiation oncology during the forecast period. The recovery in HDR therapy is quicker, as patients need to allocate one to two days’ time in hospitals for the therapy.
The low-dose rate (LDR) brachytherapy segment is projected to hold a considerable revenue share of the market during the projection period. The LDR therapy is evidence-based in gaining excellent oncologic results. This therapy is commonly used for treating prostate cancer. The introduction of advanced products to carry out LDR brachytherapy for different cancer types is likely to aid the segment’s growth in the coming years.
On the basis of device, the global market is segregated into applicators, seeds, and after loaders. The seeds segment is projected to register a significant CAGR during the forecast period. Seeds brachytherapy devices are capable of delivering high-dose radiation to cancer-affected body parts over a longer duration, owing to this benefit, their use has increased in brachytherapy treatments. The technological advancements are aiding in preventing the migration of seed implants and making them highly efficient in delivering targeted radiation to cancer tissues.
The applicators segment is also expected to expand at a rapid pace during the forecast period. Applicators are minimally invasive and highly efficient in killing cancer tissues, owing to this its preference is high amongst the cancer patients who opt for brachytherapy. The key players in the market are introducing advanced products, which is also driving the market.
Based on application, the global brachytherapy market is divided into breast cancer, prostate cancer, gynecological cancer, cervical cancer, skin cancer, and others. The prostate cancer segment is expected to expand at the fastest growth rate during the projected period. As per several studies reported, prostate cancer is the second most commonly occurring cancer in men and the fourth most occurring cancer in overall cancer cases across the world.
An increase in prostate cancer diagnostics around the world is expected to fuel the demand for brachytherapy afterloader. Prostate brachytherapy is highly effective in treating prostate cancer, due to which it is preference is increasing in cancer treatment taking patients for getting quick relief.
The breast cancer segment is also anticipated to grow at a rapid pace owing to the increasing breast cancer diagnostics worldwide. Brachytherapy afterloader is used for accelerated partial breast irradiation, which is fueling the segment growth in the market. It is commonly used for treating early-stage breast cancers to efficiently prevent cancer spread in healthy tissues.
In terms of region, the global brachytherapy market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market size of North America is expected to dominate the market during the forecast period. The growth of the market in the region is owing to the high presence of key market players and the adoption of technological advancement in providing brachytherapy by healthcare establishments in the region.
The healthcare sector in North America has widely adopted advanced treatments and equipment for treating cancer patients efficiently. The increasing prevalence of breast cancer, prostate cancer, and skin cancer, among others in the region, is also aiding the market growth in the region.
Asia Pacific is projected to be the second fastest-growing region in the global brachytherapy market during the projection period. The growing budget for advanced healthcare treatment by the government and the private players is anticipated to aid the market growth in the region. In addition, the large population of the developing economies of the region such as China and India, and high disposable income factors are fueling the demand for advanced cancer therapies in the Asia Pacific.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Brachytherapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Brachytherapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Brachytherapy Market - Supply Chain
4.5. Global Brachytherapy Market Forecast
4.5.1. Brachytherapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Brachytherapy Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Brachytherapy Market Absolute $ Opportunity
5. Global Brachytherapy Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Brachytherapy Market Size and Volume Forecast by Applications
5.3.1. Breast Cancer
5.3.2. Prostate Cancer
5.3.3. Gynecological Cancer
5.3.4. Cervical Cancer
5.3.5. Skin Cancer
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Brachytherapy Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Brachytherapy Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Brachytherapy Demand Share Forecast, 2019-2026
7. North America Brachytherapy Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Brachytherapy Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Brachytherapy Market Size and Volume Forecast by Applications
7.4.1. Breast Cancer
7.4.2. Prostate Cancer
7.4.3. Gynecological Cancer
7.4.4. Cervical Cancer
7.4.5. Skin Cancer
7.4.6. Others
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Brachytherapy Demand Share Forecast, 2019-2026
8. Latin America Brachytherapy Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Brachytherapy Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Brachytherapy Market Size and Volume Forecast by Applications
8.4.1. Breast Cancer
8.4.2. Prostate Cancer
8.4.3. Gynecological Cancer
8.4.4. Cervical Cancer
8.4.5. Skin Cancer
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Brachytherapy Demand Share Forecast, 2019-2026
9. Europe Brachytherapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Brachytherapy Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Brachytherapy Market Size and Volume Forecast by Applications
9.4.1. Breast Cancer
9.4.2. Prostate Cancer
9.4.3. Gynecological Cancer
9.4.4. Cervical Cancer
9.4.5. Skin Cancer
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Brachytherapy Demand Share Forecast, 2019-2026
10. Asia Pacific Brachytherapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Brachytherapy Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Brachytherapy Market Size and Volume Forecast by Applications
10.4.1. Breast Cancer
10.4.2. Prostate Cancer
10.4.3. Gynecological Cancer
10.4.4. Cervical Cancer
10.4.5. Skin Cancer
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Brachytherapy Demand Share Forecast, 2019-2026
11. Middle East & Africa Brachytherapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Brachytherapy Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Brachytherapy Market Size and Volume Forecast by Applications
11.4.1. Breast Cancer
11.4.2. Prostate Cancer
11.4.3. Gynecological Cancer
11.4.4. Cervical Cancer
11.4.5. Skin Cancer
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Brachytherapy Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Brachytherapy Market: Market Share Analysis
12.2. Brachytherapy Distributors and Customers
12.3. Brachytherapy Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Elekta
12.4.2. Isoray Inc.
12.4.3. iCAD Inc.
12.4.4. BEBIG Medical GmbH
12.4.5. Theragenics
12.4.6. CIVCO Medical Solutions
12.4.7. BD
12.4.8. Sun Nuclear Corporation
12.4.9. Panacea Medical Technologies Pvt. Ltd.
12.4.10. Merit Medical Systems.
12.4.11. Varian Medical Systems, Inc.
12.4.12. ARGON MEDICAL
12.4.13. Best Vascular, Inc.
12.4.14. Boston Scientific Corporation
12.4.15. Best Theratronics Ltd
12.4.16. CNMC Company Inc.
12.4.17. MEDraysintell
12.4.18. Best Medical International, Inc.
12.4.19. SIR-Spheres
12.4.20. Hologic, Inc.
12.4.21. Xoft, Inc.
12.4.22. AngioDynamics
12.4.23. IsoAid